The HarbourVest London Team

Corentin du Roy, CFA

Managing Director


About Corentin

Corentin du Roy joined HarbourVest in 2003 and focuses on direct co-investments in buyout and growth equity transactions in Europe and around the world. He serves as a director of EA Pharma. He serves on the Firm’s Direct Investment Committee and led several of the Firm’s investments including Inelo (acquired by Eurowag), Deliveroo, Eaton Towers (acquired by American Tower), Klarna, Marle, GTS Central Europe (acquired by Deutsche Telekom), Omega Pharma (acquired by Perrigo), Minimax, Prosol (Grand Frais), Nycomed (acquired by Takeda), Kiala (acquired by UPS), and Loxam.

He joined the Firm from AXA Investment Managers, where he was an equity and high-yield debt research analyst focusing mainly on the telecom sector.

Fluent in French, Corentin received a BS (with distinction) in Business Administration from Paris IX Dauphine University in 1999 and received the Chartered Financial Analyst designation in 2002.

Continuation solutions encompass a host of transaction types in which a GP secures interim liquidity and/or additional primary capital for their LPs in a strongly performing asset, or set of assets, that the GP will continue to own and control. Specifically, they include continuation funds, new funds created by GPs for the purpose of acquiring the asset(s) that continue to be managed by the same GP and capitalized by one or several secondary buyers, or equity recapitalizations involving a direct equity or structured equity investment into a portfolio company. These transactions can also include a parallel investment from the GP’s latest fund into that same pool of assets (a “cross-fund trade”).